![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Summit Therapeutics Inc | NASDAQ:SMMT | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.06 | -0.53% | 11.19 | 11.11 | 11.20 | 11.57 | 10.98 | 11.57 | 1,484,199 | 23:23:36 |
Summit Therapeutics plc (‘Summit’ or the ‘Company’)
Summit Therapeutics to Present at Upcoming Conferences
Oxford, UK, and Cambridge, MA, US, 18 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, announces that management will present at two upcoming conferences.
Details of the conference presentations:
A live webcast of the Oppenheimer presentation will be available in the Investors section of the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.
About Summit Therapeutics Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients, and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for C. difficile infection and gonorrhoea and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.
Contacts
Summit | ||
Glyn Edwards / Richard Pye (UK office) | Tel: | 44 (0)1235 443 951 |
Michelle Avery (US office) | +1 617 225 4455 | |
Cairn Financial Advisers LLP (Nominated Adviser) | Tel: | +44 (0)20 7213 0880 |
Liam Murray / Tony Rawlinson | ||
N+1 Singer (Joint Broker) | Tel: | +44 (0)20 7496 3000 |
Aubrey Powell / Jen Boorer, Corporate FinanceTom Salvesen, Corporate Broking | ||
Bryan Garnier & Co Limited (Joint Broker) | Tel: | +44 (0)20 7332 2500 |
Phil Walker / Dominic Wilson | ||
MSL Group (US) | Tel: | +1 781 684 6557 |
Jon Siegal | summit@mslgroup.com | |
Consilium Strategic Communications (UK) | Tel: | +44 (0)20 3709 5700 |
Mary-Jane Elliott / Sue Stuart / Jessica Hodgson / | summit@consilium-comms.com | |
Lindsey Neville |
-END-
1 Year Summit Therapeutics Chart |
1 Month Summit Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions